Eslicarbazepine Acetate as Therapy in Diabetic Neuropathic Pain

Clinical trial NCT01129960 · TERMINATED

Trial details

NCT number: NCT01129960
Sponsor: Bial - Portela C S.A.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Painful Diabetic Neuropathy

Start date: 2010-11-01
Primary completion: 2012-04-01
Enrollment: 332

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.